Table 2.
Estimated cost per nonfatal dengue episode by component and setting (2017 US$)
| Component | |||||
|---|---|---|---|---|---|
| Treatment setting | Direct medical | Direct not medical | Indirect | % Positive* | Total cost |
| Ambulatory (all) | 14.89 (7.96–21.81) | 5.31 (2.82–7.81) | 2.24 (0–4.54) | 29 (10–49) | 22.45 (14.12–30.77) |
| Puskesmas | 6.94 (5.67–8.20) | 3.46 (1.67–5.24) | 2.66 (0–5.85) | 29 (5–54) | 13.05 (8.83–17.27) |
| Hospital outpatient | 34.19 (15.68–52.71) | 9.83 (2.20–17.46) | 1.24 (0–3.98) | 29 (0–74) | 45.26 (25.57–64.95) |
| Hospitalized (all) | 260.62 (195.27–325.97) | 33.95 (23.61–44.30) | 21.67 (8.81–34.54) | 65 (42–88) | 316.24 (242.30–390.18) |
| Type A/B hospital | 372.99 (236.69–509.30) | 39.05 (19.17–58.94) | 35.18 (2.78–67.57) | 75 (36–100) | 447.22 (298.81–595.63) |
| Type C/D hospital | 185.70 (145.21–226.20) | 30.55 (19.04–42.06) | 12.67 (5.01–20.33) | 58 (26–90) | 228.92 (190.01–267.83) |
| Not medically attended | 0.93 (0.40–1.45) | 3.36 (1.83–4.88) | 3.19(0.00–7.05) | 13 (0–28) | 7.48 (2.36–12.60) |
| All (weighted average)† | 37.35 (27.07–47.63) | 7.72 (4.84–10.59) | 5.34 (1.13–9.99) | 23 (8–40) | 50.41(35.75–65.07) |
*
% Positive indicates the proportion of respondents in each setting who lost income, that is, with positive (nonzero) indirect costs.
†
The central estimates of the number of nonfatal cases by setting from Table 3 are used as the weights for combining settings here and in Table 3. The lower and upper bound estimates are the weighted averages of the lower and upper bounds of cost per episode in each setting, a procedure which provides the widest possible range. The range in parentheses below each entry is its 95% uncertainty interval.